Antiepileptic Drugs in Mood-Disordered Patients

Authors


  • The first and second authors contributed equally to the article.

Address correspondence and reprint requests to Dr. H. Grunze at Department of Psychiatry, LMU Munich, Nussbaumstr. 7, 80336 Munich, Germany. E-mail: Heinz.Grunze@med.uni-muenchen.de

Abstract

Summary:  Bipolar disorder is a common, recurrent, often severe mental disorder that, without adequate treatment, is associated with high rates of morbidity and mortality. We review the evidence on the efficacy of a spectrum of antiepileptic drugs (AED) in bipolar disorder. Most studies have been carried out with carbamazepine (CBZ), valproate (VPA), and lamotrigine (LTG). All three of these AEDs have been shown to be of value in the management of patients with bipolar illnesses. VPA and CBZ seem to exert stronger antimanic effects and, to a lesser degree, acute antidepressant efficacy. LTG seems to be effective against depression and mania, with a more robust activity against depression. No firm evidence supports a role for vigabatrin, tiagabine, topiramate, or levetiracetam in these disorders.

Ancillary